Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Phase I trials assess safety, tolerability and pharmacokinetics of ASM-024

Oct. 19, 2010

Preclinical and clinical data presented on antibiotic CB-183315

Oct. 19, 2010

Snapshots: Preclinical and early clinical development of GSK-1322322

Oct. 18, 2010

Scientists explore antibacterial potential of GE-2270 analogues

Oct. 18, 2010

OC-000459 inhibits late-phase airway response after allergen challenge in patients with asthma

Oct. 18, 2010

Tiotropium/olodaterol combination more effective than tiotropium in COPD

Oct. 18, 2010

Trius Therapeutics develops new antimicrobials targeting dihydrofolate reductase

Oct. 18, 2010

Almirall presents pharmacological profile of LAS-189913, a new candidate therapeutic for MS

Oct. 15, 2010

Preclinical and phase I data presented on Algipharma's OligoG

Oct. 15, 2010

Continuous exenatide delivery with ITCA-650 shows promise in phase II diabetes trial

Oct. 15, 2010

Popular Stories

Today's news in brief
BioWorld
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...